|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
NLM036425990 |
| 003 |
DE-627 |
| 005 |
20250126221137.0 |
| 007 |
tu |
| 008 |
231221s1987 xx ||||| 00| ||jpn c |
| 028 |
5 |
2 |
|a pubmed25n0122.xml
|
| 035 |
|
|
|a (DE-627)NLM036425990
|
| 035 |
|
|
|a (NLM)3661345
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a jpn
|
| 100 |
1 |
|
|a Banya, Y
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Clinical experience with cefbuperazone in complicated urinary tract infection
|
| 264 |
|
1 |
|c 1987
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 18.11.1987
|
| 500 |
|
|
|a Date Revised 23.11.2016
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Cefbuperazone (CBPZ) was administered to inpatients with complicated urinary tract infections (UTI) at our department. Clinical efficacy and safety were evaluated in 22 chronic cases by the criteria for evaluation of clinical of antimicrobial agents on urinary tract infection. Overall clinical efficacy was excellent in 8 cases, moderate in 9 cases and poor in 5 cases with an effectiveness rate of 77%. Twenty-four of the 34 strains isolated from the patients were eradicated and eradication rate was 71%. Neither subjective nor objective adverse reactions were observed. Abnormal changes in laboratory tests were found in 9 patients, but were probably not related to CBPZ administration. Judging from these results, CBPZ is considered to be an effective and safe antibacterial for the treatment of complicated UTI
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
7 |
|a Cephamycins
|2 NLM
|
| 650 |
|
7 |
|a cefbuperazone
|2 NLM
|
| 650 |
|
7 |
|a T0785J3X40
|2 NLM
|
| 700 |
1 |
|
|a Okamoto, T
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Ujiie, T
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Yoo, T
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Noro, K
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Niisato, S
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Yokota, K
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Aoki, H
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Kubo, T
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Ohhori, T
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Hinyokika kiyo. Acta urologica Japonica
|d 1962
|g 33(1987), 5 vom: 01. Mai, Seite 786-93
|w (DE-627)NLM012631779
|x 0018-1994
|7 nnns
|
| 773 |
1 |
8 |
|g volume:33
|g year:1987
|g number:5
|g day:01
|g month:05
|g pages:786-93
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_20
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_60
|
| 912 |
|
|
|a GBV_ILN_72
|
| 912 |
|
|
|a GBV_ILN_120
|
| 912 |
|
|
|a GBV_ILN_350
|
| 912 |
|
|
|a GBV_ILN_2001
|
| 912 |
|
|
|a GBV_ILN_2003
|
| 912 |
|
|
|a GBV_ILN_2005
|
| 912 |
|
|
|a GBV_ILN_2006
|
| 912 |
|
|
|a GBV_ILN_2008
|
| 912 |
|
|
|a GBV_ILN_2010
|
| 912 |
|
|
|a GBV_ILN_2012
|
| 912 |
|
|
|a GBV_ILN_2018
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 33
|j 1987
|e 5
|b 01
|c 05
|h 786-93
|